.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Julphar
Baxter
Chubb
McKinsey
Citi
Johnson and Johnson
US Army
AstraZeneca
Farmers Insurance

Generated: September 26, 2017

DrugPatentWatch Database Preview

Drug Master Files for: piroxicam

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
7130III8/25/1987FABBRICA ITALIANA SINTETICI SPAPIROXICAM
7447III3/15/1988WOCKHARDT LTDPIROXICAM
7472AII5/11/1988DIPHARMA FRANCIS SRLPIROXICAM
7473III5/13/1988MOEHS SA DIV SANOFPIROXICAM
7585III7/14/1988EGIS PHARMACEUTICALS PRIVATE LTDPIROXICAM
7660III8/31/1988SIBEFAT SPAPIROXICAM
7697III9/29/1988ESTEVE QUIMICA SAPIROXICAM
8055III5/4/1989KRKA PHARMACEUTICAL AND CHEMICAL WORKSPIROXICAM
8184III8/28/1989NANTONG PHARMACEUTICAL FACTORYPIROXICAM
8231III10/3/1989MEDICHEM SAPIROXICAM
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Colorcon
Cipla
Express Scripts
Mallinckrodt
Chubb
Queensland Health
Dow
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot